
### [NCIT:C39852](http://purl.obolibrary.org/obo/NCIT_C39852)
**Label:** Urothelial Neoplasm

**Subclasses:** [NCIT:C4597](http://purl.obolibrary.org/obo/NCIT_C4597) (Stage 0is Renal Pelvis Urothelial Carcinoma), [NCIT:C4830](http://purl.obolibrary.org/obo/NCIT_C4830) (Ureter Urothelial Carcinoma), [NCIT:C6174](http://purl.obolibrary.org/obo/NCIT_C6174) (Ureter Inverted Papilloma), [NCIT:C7383](http://purl.obolibrary.org/obo/NCIT_C7383) (Bladder Papillary Urothelial Carcinoma), [NCIT:C6173](http://purl.obolibrary.org/obo/NCIT_C6173) (Urethral Inverted Papilloma), [NCIT:C4030](http://purl.obolibrary.org/obo/NCIT_C4030) (Urothelial Carcinoma), [NCIT:C39831](http://purl.obolibrary.org/obo/NCIT_C39831) (Non-Invasive Bladder Papillary Urothelial Neoplasm), [NCIT:C39879](http://purl.obolibrary.org/obo/NCIT_C39879) (Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C7517](http://purl.obolibrary.org/obo/NCIT_C7517) (Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C27885](http://purl.obolibrary.org/obo/NCIT_C27885) (Infiltrating Bladder Urothelial Carcinoma), [NCIT:C27882](http://purl.obolibrary.org/obo/NCIT_C27882) (Bladder Low Grade Intraurothelial Neoplasia), [NCIT:C115966](http://purl.obolibrary.org/obo/NCIT_C115966) (Infiltrating Bladder Urothelial Carcinoma Associated with Urethral Carcinoma), [NCIT:C27883](http://purl.obolibrary.org/obo/NCIT_C27883) (Papillary Urothelial Neoplasm), [NCIT:C7518](http://purl.obolibrary.org/obo/NCIT_C7518) (Stage 0is Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C7716](http://purl.obolibrary.org/obo/NCIT_C7716) (Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C8603](http://purl.obolibrary.org/obo/NCIT_C8603) (Renal Pelvis Papillary Urothelial Neoplasm), [NCIT:C6149](http://purl.obolibrary.org/obo/NCIT_C6149) (Stage 0 Ureter Urothelial Carcinoma), [NCIT:C27880](http://purl.obolibrary.org/obo/NCIT_C27880) (Intraurothelial Neoplasia), [NCIT:C6148](http://purl.obolibrary.org/obo/NCIT_C6148) (Renal Pelvis Papillary Urothelial Carcinoma), [NCIT:C39829](http://purl.obolibrary.org/obo/NCIT_C39829) (Infiltrating Bladder Urothelial Carcinoma with Giant Cells), [NCIT:C7355](http://purl.obolibrary.org/obo/NCIT_C7355) (Renal Pelvis Urothelial Carcinoma), [NCIT:C6188](http://purl.obolibrary.org/obo/NCIT_C6188) (Stage 0 Bladder Urothelial Carcinoma), [NCIT:C8168](http://purl.obolibrary.org/obo/NCIT_C8168) (Regional Urothelial Carcinoma of the Renal Pelvis and Ureter), [NCIT:C8167](http://purl.obolibrary.org/obo/NCIT_C8167) (Localized Urothelial Carcinoma of the Renal Pelvis and Ureter), [NCIT:C6187](http://purl.obolibrary.org/obo/NCIT_C6187) (Renal Pelvis Inverted Papilloma), [NCIT:C6186](http://purl.obolibrary.org/obo/NCIT_C6186) (Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant), [NCIT:C6192](http://purl.obolibrary.org/obo/NCIT_C6192) (Inverted Urothelial Papilloma), [NCIT:C6191](http://purl.obolibrary.org/obo/NCIT_C6191) (Stage I Bladder Urothelial Carcinoma), [NCIT:C39820](http://purl.obolibrary.org/obo/NCIT_C39820) (Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant), [NCIT:C5061](http://purl.obolibrary.org/obo/NCIT_C5061) (Urethral Urothelial Papilloma), [NCIT:C6193](http://purl.obolibrary.org/obo/NCIT_C6193) (Stage 0 Renal Pelvis Urothelial Carcinoma), [NCIT:C39826](http://purl.obolibrary.org/obo/NCIT_C39826) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements), [NCIT:C39825](http://purl.obolibrary.org/obo/NCIT_C39825) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements), [NCIT:C4528](http://purl.obolibrary.org/obo/NCIT_C4528) (Renal Pelvis Urothelial Papilloma), [NCIT:C39821](http://purl.obolibrary.org/obo/NCIT_C39821) (Infiltrating Bladder Lymphoepithelioma-Like Carcinoma), [NCIT:C4529](http://purl.obolibrary.org/obo/NCIT_C4529) (Stage 0is Ureter Urothelial Carcinoma), [NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma), [NCIT:C39824](http://purl.obolibrary.org/obo/NCIT_C39824) (Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant), [NCIT:C3842](http://purl.obolibrary.org/obo/NCIT_C3842) (Urothelial Papilloma), [NCIT:C39819](http://purl.obolibrary.org/obo/NCIT_C39819) (Infiltrating Bladder Urothelial Carcinoma, Nested Variant), [NCIT:C39818](http://purl.obolibrary.org/obo/NCIT_C39818) (Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation), [NCIT:C3644](http://purl.obolibrary.org/obo/NCIT_C3644) (Stage 0is Bladder Urothelial Carcinoma), [NCIT:C6156](http://purl.obolibrary.org/obo/NCIT_C6156) (Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation), [NCIT:C6157](http://purl.obolibrary.org/obo/NCIT_C6157) (Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation), [NCIT:C8254](http://purl.obolibrary.org/obo/NCIT_C8254) (Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter), [NCIT:C27634](http://purl.obolibrary.org/obo/NCIT_C27634) (Transplant-Related Bladder Urothelial Carcinoma), [NCIT:C9267](http://purl.obolibrary.org/obo/NCIT_C9267) (Stage 0a Bladder Urothelial Carcinoma), [NCIT:C27876](http://purl.obolibrary.org/obo/NCIT_C27876) (Non-Invasive Bladder Papillary Urothelial Carcinoma, High Grade), [NCIT:C39851](http://purl.obolibrary.org/obo/NCIT_C39851) (Bladder Urothelial Carcinoma), [NCIT:C39850](http://purl.obolibrary.org/obo/NCIT_C39850) (Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C8064](http://purl.obolibrary.org/obo/NCIT_C8064) (Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter), [NCIT:C39853](http://purl.obolibrary.org/obo/NCIT_C39853) (Infiltrating Urothelial Carcinoma), [NCIT:C126307](http://purl.obolibrary.org/obo/NCIT_C126307) (Recurrent Bladder Urothelial Carcinoma), [NCIT:C126109](http://purl.obolibrary.org/obo/NCIT_C126109) (Metastatic Urothelial Carcinoma), [NCIT:C6160](http://purl.obolibrary.org/obo/NCIT_C6160) (Ureter Urothelial Papilloma), [NCIT:C39859](http://purl.obolibrary.org/obo/NCIT_C39859) (Bladder Inverted Papilloma), [NCIT:C39858](http://purl.obolibrary.org/obo/NCIT_C39858) (Bladder Urothelial Papilloma), [NCIT:C39817](http://purl.obolibrary.org/obo/NCIT_C39817) (Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation), [NCIT:C39816](http://purl.obolibrary.org/obo/NCIT_C39816) (Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation), [NCIT:C39854](http://purl.obolibrary.org/obo/NCIT_C39854) (Non-Invasive Urothelial Neoplasm), [NCIT:C39898](http://purl.obolibrary.org/obo/NCIT_C39898) (Primary Prostate Urothelial Carcinoma), [NCIT:C39857](http://purl.obolibrary.org/obo/NCIT_C39857) (Bladder Papillary Urothelial Neoplasm), [NCIT:C8939](http://purl.obolibrary.org/obo/NCIT_C8939) (Stage II Bladder Urothelial Carcinoma), [NCIT:C6203](http://purl.obolibrary.org/obo/NCIT_C6203) (Stage 0a Ureter Urothelial Carcinoma), [NCIT:C8940](http://purl.obolibrary.org/obo/NCIT_C8940) (Stage III Bladder Urothelial Carcinoma), [NCIT:C6166](http://purl.obolibrary.org/obo/NCIT_C6166) (Urethral Urothelial Carcinoma), [NCIT:C8941](http://purl.obolibrary.org/obo/NCIT_C8941) (Stage IV Bladder Urothelial Carcinoma), [NCIT:C6202](http://purl.obolibrary.org/obo/NCIT_C6202) (Stage 0a Renal Pelvis Urothelial Carcinoma), [NCIT:C37266](http://purl.obolibrary.org/obo/NCIT_C37266) (Bladder Flat Intraepithelial Lesion), [NCIT:C131218](http://purl.obolibrary.org/obo/NCIT_C131218) (Recurrent Urethral Urothelial Carcinoma), [NCIT:C39844](http://purl.obolibrary.org/obo/NCIT_C39844) (Bladder Urachal Urothelial Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 56.56%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) 52.31%
- [CL:0000244](http://purl.obolibrary.org/obo/CL_0000244) (transitional epithelial cell) 52.31%
- [UBERON:0001255](http://purl.obolibrary.org/obo/UBERON_0001255) (urinary bladder) 50.77%
- [NCIT:C54557](http://purl.obolibrary.org/obo/NCIT_C54557) (Renal Pelvis Urothelial Cell) 50.77%
- [NCIT:C39875](http://purl.obolibrary.org/obo/NCIT_C39875) (Loss of Chromosome 9q) 50.77%
- [NCIT:C39716](http://purl.obolibrary.org/obo/NCIT_C39716) (EGFR Protein Overexpression) 50.77%
- [NCIT:C36681](http://purl.obolibrary.org/obo/NCIT_C36681) (MDM2 Gene Amplification) 50.77%
- [NCIT:C36679](http://purl.obolibrary.org/obo/NCIT_C36679) (HRAS Gene Amplification) 50.77%
- [NCIT:C36652](http://purl.obolibrary.org/obo/NCIT_C36652) (CCND1 Gene Amplification) 50.77%
- [NCIT:C36649](http://purl.obolibrary.org/obo/NCIT_C36649) (EGFR Gene Amplification) 50.77%
- [NCIT:C36639](http://purl.obolibrary.org/obo/NCIT_C36639) (ERBB2 Protein Overexpression) 50.77%
- [NCIT:C36638](http://purl.obolibrary.org/obo/NCIT_C36638) (ERBB2 Gene Amplification) 50.77%
- [NCIT:C36636](http://purl.obolibrary.org/obo/NCIT_C36636) (Loss of Chromosome 9p) 50.77%
- [NCIT:C36599](http://purl.obolibrary.org/obo/NCIT_C36599) (Loss of Chromosome Y) 50.77%


